Health Strategies Group
Subscriber login
Who we are What_we_do News Careers Contact us
Health Strategies Group Introduces Cross-Category Access, November 19, 2009
Lambertville, NJ – Health Strategies Group, a leading consulting firm providing market intelligence and research to pharmaceutical and biotechnology professionals, announces its newest service, Cross-Category Access a new market intelligence service that provides strategic, future-oriented insights into health plan access decisions across more than 20 drug categories.

“The development of this new service comes from the unmet needs expressed by our clients for more in-depth, future focused multi-category analysis,” states Susan Weber, Research Director, Cross-Category Access. “Our research leverages insights into more than 20 drug categories to improve brand access across inline and prelaunch portfolios.”

Cross-Category Access includes three key sections of analysis plus access to Health Strategies Group experts with brand marketing and health plan brand management expertise, who help clients apply the marketing intelligence to their business objectives. Analysis includes:

Trends Analysis: Defines impact of emerging payer trends on current and future category access decisions by health plans.

Benchmarking Analysis: Benchmarks access decision drivers across more than 20 categories to rigorously identify opportunities and barriers to access.

Case Studies: Presents case studies on category-changing market events and their effect on how health plans manage drug categories.

For additional information on Cross-Category Access, contact Karen Vandeven, Director of Marketing Communications for Health Strategies Group, at (609) 397-5282 or kvandeven@healthstrategies.com.





Media and industry groups frequently ask us to serve as resources. Learn more about topics we can address.

Karen Vandeven
Director, Marketing & Communications
vandeven@healthstrategies.com 609.397.5282 ext.324